Ann: Investor Presentation, page-12

I've looked at the broker data for the this/past week and quite a few insto brokers as net buyers. Commsec was a net seller.

Fascinating watching how quickly sentiment changes (for literally no reason) and all the panic that manifests out of nowhere. Throw in a few posts from rampers that have been calling it overvalued from 30c and you have a perfect storm, with people stumbling as they rush for the exit.

That's fine. We needed to re-enter an accumulation mode anyways. Might take weeks/months, who knows. Broker data doesn't lie and was reassuring for me personally validating what I already thought was happening.

I'm copy/pasting below the notes that Pac Partners put out post their cannabis conference last week where AGH presented amongst some of the biggest names in Australian/Canadian cannabis companies:

Althea is one of the key leaders in the burgeoning patient access market for medicinal cannabis, and is poised to capitalise on the strong patient growth.
AGH currently has ‘well over’ 2,000 patients, and CEO Josh Fegan reaffirmed the target of 4,000 patients by the end of the calendar year.
The UK market is still in the early phase of adoption, Althea has supplied more than ~12 prescriptions, of a market that currently consists of only ~50 – 60 patients.
AGH is set to establish 3 clinics under the ‘MyAccess’ brand across the UK, along with the granting of their bulk import permit, AGH will have the capacity to add thousands of patients within months.

Just my 2c.